Comments
Bharat Biotech has won the `Best Production /Process Development’ award as part of the Vaccine Industry Excellence (ViE) awards at the World Vaccine Congress 2023.
The Congress was held during April 3-6 in Washington, USA.
Hyderabad-based Bharat Biotech was the only Indian company in the list of VIE awards in various categories, including best clinical trial company, best clinical trial network, best central/specialty laboratory award, best contract research organisation, best production/process development award, among others.
Read also: More power for pharma
Bharat Biotech is the world’s first producer of intranasal Covid-19 vaccine, iNcovacc. Its intramuscular vaccine, Covaxin, is part of India’s public vaccination programme and was also exported.
Read more: All about iNcovacc, the intranasal Covid-19 vaccine of Bharat Biotech
The World Vaccine Congress is the largest global meeting dedicated to vaccines. From basic research to commercial manufacture, it covers the whole vaccine value chain. Apart from uniting vaccine experts, it was instrumental in sharing groundbreaking knowledge in tackling the pandemic.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.